These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 942759)

  • 61. [Exposure to diethylstilbestrol during pregnancy as a cause for developmental abnormalities of the genitalia].
    Santti R; Mäkelä S; Pylkkänen L
    Duodecim; 1990; 106(18):1242-8. PubMed ID: 1670552
    [No Abstract]   [Full Text] [Related]  

  • 62. Study of prenatal DES exposure and its consequences in Rochester, Minnesota.
    Noller KL; Kurland LT
    J Toxicol Environ Health Suppl; 1976; 1():1-11. PubMed ID: 994228
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Vaginal cancer composed from clear cells found in a girl aged 18 years whose mother was treated during pregnancy by diethylsilbestrol (Agostilben) (author's transl)].
    Krupa J; Pelikán K
    Cesk Gynekol; 1977 May; 42(4):264-8. PubMed ID: 862055
    [No Abstract]   [Full Text] [Related]  

  • 64. [Does diethylstilbestrol also affect the ovaries of the fetus?].
    Eskes TK; Scheres JM
    Ned Tijdschr Geneeskd; 1984 Aug; 128(34):1601-3. PubMed ID: 6483030
    [No Abstract]   [Full Text] [Related]  

  • 65. The Diethylstilbestrol (DES) exposed female in Maine. A discussion with suggestions regarding identification and management applicable to our state.
    Zerner J; Wilkis JL; Fenn ME
    J Maine Med Assoc; 1976 Jun; 67(6):163-5. PubMed ID: 932552
    [No Abstract]   [Full Text] [Related]  

  • 66. Colposcopic evaluation of stilbestrol exposed young women.
    Marlow JL
    Med Ann Dist Columbia; 1974 Oct; 43(10):503-6. PubMed ID: 4529412
    [No Abstract]   [Full Text] [Related]  

  • 67. [Possible carcinogenic action of sex hormones in the perinatal period of ontogeny].
    Ird EA; Smirnov IO
    Akush Ginekol (Mosk); 1978 Dec; (12):4-7. PubMed ID: 367193
    [No Abstract]   [Full Text] [Related]  

  • 68. DES: its use and effects as contraceptive and additive.
    Rauscher FJ
    Conn Med; 1975 Jul; 39(7):439-40. PubMed ID: 1157496
    [No Abstract]   [Full Text] [Related]  

  • 69. Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins.
    Christian MS; Brent RL; Calda P
    J Matern Fetal Neonatal Med; 2007 Feb; 20(2):89-112. PubMed ID: 17437208
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Research findings of potential value to the practitioner.
    JAMA; 1977 Aug; 238(6):471-2. PubMed ID: 577565
    [No Abstract]   [Full Text] [Related]  

  • 71. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
    Brancazio LR; Murtha AP; Heine RP
    N Engl J Med; 2003 Sep; 349(11):1087-8; author reply 1087-8. PubMed ID: 12968095
    [No Abstract]   [Full Text] [Related]  

  • 72. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
    EICHNER E
    Ann N Y Acad Sci; 1958 Jul; 71(5):787-93. PubMed ID: 13583833
    [No Abstract]   [Full Text] [Related]  

  • 73. Pseudopolyp of uterine cervix.
    Evrard JR
    Am J Obstet Gynecol; 1973 Jun; 116(4):590. PubMed ID: 4709501
    [No Abstract]   [Full Text] [Related]  

  • 74. Editorial: Prenatal cestrogen-continued.
    Lancet; 1975 Apr; 1(7913):960-7. PubMed ID: 48129
    [No Abstract]   [Full Text] [Related]  

  • 75. A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor.
    Bréart G; Lanfranchi M; Chavigny C; Rumeau-Rouquette C; Sureau C
    Int J Gynaecol Obstet; 1979; 16(5):381-4. PubMed ID: 86468
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Letter: Congenital heart defects and prenatal sex hormones.
    Mulvihill JJ; Mulvihill CG; Neill CA
    Lancet; 1974 Jun; 1(7867):1168. PubMed ID: 4136887
    [No Abstract]   [Full Text] [Related]  

  • 77. Letter: Prenatal diethylstilboestrol exposure and male hypogonadism.
    Hoefnagel D
    Lancet; 1976 Jan; 1(7951):152-3. PubMed ID: 54671
    [No Abstract]   [Full Text] [Related]  

  • 78. Prenatal 'female hormone' administration and psychosexual development in human males.
    Kester P; Green R; Finch SJ; Williams K
    Psychoneuroendocrinology; 1980 Dec; 5(4):269-85. PubMed ID: 7208750
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of prenatal drugs on the behavior of the neonate.
    Brazelton TB
    Am J Psychiatry; 1970 Mar; 126(9):1261-6. PubMed ID: 4905017
    [No Abstract]   [Full Text] [Related]  

  • 80. Metabolic effects of beta-adrenoceptor agonists on mother and fetus.
    Bengtsson B; Andersson KE
    Acta Pharmacol Toxicol (Copenh); 1979; 44 Suppl 2():76-83. PubMed ID: 41402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.